Featured
Last news
Intimate no more? Japan clamps down on 'host clubs'
Japan is waging war on "host clubs" -- where men entertain women willing to pay for romance, but authorities and industry insiders say customers have long been scammed and saddled with debt.
Huge quake off Russia sparks Pacific tsunami warnings
Tsunamis hit parts of Russia's Far East and Japan on Wednesday after a huge magnitude 8.8 earthquake, with warnings in place around the Pacific of waves of over three metres (10 feet) in places.
Portugal battles to contain wildfires
Almost 2,700 firefighters battled Tuesday to contain forest blazes across Portugal that have led to almost the whole country being put on high alert for fires.
Aspire Biopharma Holdings, Inc. Announces CEO Transition
Kraig Higginson, Current Chairman of the Board, Appointed Interim CEO
Nepra Foods Announces Delay in Filing Annual Financial Statements
VANCOUVER, BC / ACCESS Newswire / July 30, 2025 / Nepra Foods Inc. (CSE:NPRA)(FSE:2P6)(OTCQB:NPRFF) ("Nepra Foods" or the "Company"), wishes to announce that its annual financial statements for the year ended March 31, 2025, including the related management discussion and analysis, and CEO and CFO certifications (collectively, the "Annual Filings"), has not been filed as required under Canadian securities legislation by the required filing deadline of July 29, 2025 (the "Filing Deadline").
Inka Health Selected by OneMedNet to Lead AI-Driven Oncology Project Using Real-World Data for External Control Arms
Reduce development timelines and costs, while improving access to life-saving treatments
Moderna Receives European Commission Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1
CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission (EC) has granted marketing authorization for the updated formulation of the COVID-19 vaccine Spikevax®, targeting the SARS-CoV-2 variant LP.8.1, for active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals six months of age and older. This marketing authorization follows the Positive Opinion from the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP). The authorization is valid in all 27 EU member states, as well as Iceland, Liechtenstein and Norway. Following the EC decision, doses will be available for eligible populations ahead of the 2025-2026 vaccination season.
Havertys Furniture Reports Operating Results for Second Quarter 2025
ATLANTA, GA / ACCESS Newswire / July 30, 2025 / Haverty Furniture Companies, Inc. (NYSE:HVT)(NYSE:HVT.A), today reported operating results for the second quarter ended June 30, 2025.
Bausch Health Announces Second Quarter 2025 Results
Second Quarter Consolidated Revenues of $2.53 billion, up 5% on a Reported basis and 4% on an Organic (non-GAAP)1 basis over the prior year periodGAAP Net Income Attributable to Bausch Health Companies of $148 million and GAAP Net Income of $128 millionConsolidated Adjusted EBITDA Attributable to Bausch Health Companies (non-GAAP)1 of $842 million, up 6% on a Reported basis over the prior year periodBAUSCH HEALTH EXCLUDING BAUSCH + LOMB SECOND QUARTER 2025 RESULTSDelivered ninth consecutive quarter of year-over-year Revenue and Adjusted EBITDA (non-GAAP)1 growth, with 5% both Reported and Organic (non-GAAP)1 Revenue growth, and 10% Adjusted EBITDA (non-GAAP)1 growthAnnounced upcoming repayment of approximately $900 million dollars of debt using cash on hand after quarter-endEntered into an agreement to acquire DURECT Corporation in July, which if all closing conditions are satisfied and the acquisition closes, will enable Bausch Health to use its hepatology expertise to seek to gain approvals and commercialize DURECT's main treatment for alcohol-induced hepatitisReaffirming full-year 2025 Revenue, Adjusted EBITDA (non-GAAP)1, and Adjusted Cash Flow from Operations (non-GAAP)1 guidance
Cosmoprof North America Las Vegas 2025 Closes With Strong Momentum
The leading B2B beauty exhibition in the Americas reaffirms its industry leadership.
New to The Street Signs NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI) to 12-Part National Broadcast Series Including T.V. Network Features, Earned Media, Commercials, and Iconic Outdoor Billboards
NEW YORK CITY, NEW YORK / ACCESS Newswire / July 30, 2025 / New to The Street, the nation's premier financial media platform for emerging public companies, proudly announces a major media partnership with NeOnc Technologies Holdings, Inc. (NASDAQ:NTHI). Under this agreement, NeOnc will be featured in a 12-part national broadcast series, with exclusive monthly interviews airing on Bloomberg Television and Fox Business Network. The series will also include earned media distribution, commercial rotation across national networks, and outdoor billboard campaigns in the most visible financial corridors in the U.S.
Tech and Innovation Reshape the Future of Fashion Sourcing at SOURCING at MAGIC Las Vegas
LAS VEGAS, NV / ACCESS Newswire / July 30, 2025 / SOURCING at MAGIC forms the foundation of the fashion supply chain, serving as the critical cornerstone where design concepts transform into market-ready creations. The event connects designers and brands with global manufacturing capabilities essential to navigate the entire supply chain journey from initial concept to final production and beyond.
New to The Street Client and HPB CEO Sounds the Alarm on Innovation Gridlock in New Book Launched at Future of Batteries Summit 2025
"Public Enemy No. 1 - Innovation" by Dr. Sebastian Heinz Lifts the Curtain on Why Breakthrough Technologies Stall-and What Must Be Done
Revolutionizing Preventive Medicine with AI Facial Biometrics: Medical Care Technologies Inc. (OTC Pink:MDCE) Leads the Charge
MESA, ARIZONA / ACCESS Newswire / July 30, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE) is redefining the future of preventive healthcare with its cutting-edge AI Facial Age-Based Health Risk Estimator-a breakthrough diagnostic tool at the intersection of artificial intelligence, computer vision, and personalized medicine.
Measles Cases Increasing Worldwide, Need the New NV-387 Broad-Spectrum Antiviral to Combat, Says NanoViricides
SHELTON, CT / ACCESS Newswire / July 30, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine technology that viruses cannot escape, announced that its drug candidate NV-387 is the weapon necessary for combatting growing cases of measles worldwide, especially in the industrialized world including, USA, Canada, UK, and European Union.
Forward Water Technologies Announces Financial Results for the Fifteen-Month Period Ended March 31, 2025
TORONTO, ON / ACCESS Newswire / July 30, 2025 / Forward Water Technologies Corp. (TSXV:FWTC) (the "Company") is pleased to announce that it has filed its condensed consolidated audited financial statements and related management's discussion and analysis for the fifteen-month period ended March 31, 2025. Copies of these financial statements and related management's discussion and analysis can be found on the Company's issuer profile at www.sedar.com. All financial information in this news release is reported in Canadian dollars, unless otherwise indicated.
South Dakota Partners with Avel eCare to Launch the First-of-Its-Kind Continuing Education (CE) Program for EMS Teams Using Real-Time Telemedicine Support
SIOUX FALLS, SD / ACCESS Newswire / July 30, 2025 / The South Dakota Department of Health in partnership with Avel eCare, a national leader in innovative telemedicine solutions, is proud to introduce a new and uniquely impactful continuing education (CE) credit opportunity for emergency medical services professionals. Beginning August 25, EMS personnel who engage Avel for a telemedicine encounter will be eligible to earn CE credit - marking a first in virtual care.
MIRA Pharmaceuticals Reports New Topical Ketamir-2 shows comparable effects to Injected Morphine in Preclinical Pain Study
Topical Ketamir-2 significantly reduced both acute and inflammatory pain behaviors in animals, demonstrating rapid onset, durable effect, and comparable efficacy to injected morphine across both pain phases
Specificity Expands to Europe, Bringing Precision Targeting and Human-Only Ad Tech to a Market Ripe for Disruption
TAMPA, FLORIDA / ACCESS Newswire / July 30, 2025 / Specificity, Inc. (OTCID:SPTY), the digital marketing powerhouse known as the nation's first, truly hybrid model for adtech and digital marketing, has very quietly launched Specificity Europe-bringing its proprietary, hyper-targeted ad tech to a market often overlooked by mar-tech due to GDPR regulations.
DEA's Marijuana Hypocrisy Laid Bare: As Rescheduling Looms, Agency's Ethical Failures and Research Obstruction Spark Outrage
Terrance Cole's First Test as AdministratorMMJ BioPharma Cultivation's case exposes DEA's Diversion Control Division as a cartel of obstructionists who have abandoned science, betrayed public trust, and refused to follow the law.New DEA Administrator Terrance Cole inherited a mess. But now he has a chance to do something Judge Mulrooney, Thomas Prevoznik, Matthew Straitand Aarathi Haig never would: Tell the truth. Follow the law. And approve MMJ's long-blocked registration so clinical trials can finally begin.
Evotec SE and Sandoz AG Planning Potential Sale of Just - Evotec Biologics Toulouse Site
HAMBURG, DE / ACCESS Newswire / July 30, 2025 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, Prime Standard, ISIN: DE 000 566480 9, WKN 566480; NASDAQ:EVO) announces the signing of a non-binding agreement with Sandoz AG (SIX:SDZ)(OTCQX:SDZNY) regarding the potential sale of Just - Evotec Biologics EU in Toulouse, France, for a consideration of about US$ 300 m in cash. In addition, the planned transaction terms include further technology related consideration, future development revenues, milestones and product royalties.
Evotec and Sandoz Evolve their Strategic Partnership and Agree on Potential Sale of Just - Evotec Biologics Toulouse Site
Evotec SE and Sandoz AG signed a non-binding term sheet on a planned sale of Just - Evotec Biologics EU in Toulouse to SandozUnder the proposed deal Evotec would transfer biosimilar manufacturing capabilities to enable Sandoz to produce biosimilar medicines using Just - Evotec Biologics' advanced continuous manufacturing technologyThe deal terms include the purchase price of the site for around US$ 300 m in cash, and in addition will include further technology related consideration, future development revenues, milestones and product royaltiesPlanned transaction marks major milestone in Evotec's strategy to create asset-lighter business model leveraging high-margin offerings, with Just - Evotec Biologics remaining core business for EvotecTransaction is expected to immediately improve Evotec's short-, mid-, and long-term revenue mix, profit margins, and capital efficiency
Tens of thousands of Catholics head to Vatican's Jubilee of Youth
Pope Leo XIV made a surprise appearance in a crowd of 120,000 young Catholics who gathered on Tuesday in Rome for the Vatican's Jubilee of Youth -- an event that takes place every 25 years.
Trump says fell out with Epstein because he was taking Mar-a-Lago spa staff
US President Donald Trump said Tuesday that he fell out with Jeffrey Epstein because the convicted sex offender had poached staff from his club's spa, including the woman at the center of an underage sex scandal involving Prince Andrew.
Tens of thousands in Rome for Vatican's Jubilee of Youth
Tens of thousands of young Catholics from all over the world gathered on Tuesday in Rome for a week of pilgrimage during the Vatican's Jubilee of Youth -- an event that takes place every 25 years.
New York mass shooter blamed NFL for his brain injuries
A man who killed four people, then committed suicide in a New York skyscraper, may have been targeting the NFL offices there because he blamed the American football league for brain injuries he said he suffered, Mayor Eric Adams said Tuesday.
LA wildfires push insurance losses to highest since 2011: Munich Re
The Los Angeles wildfires drove insured natural disaster losses in the first half of the year to their highest level since Japan's Fukushima disaster in 2011, German reinsurance giant Munich Re said Tuesday.
Five dead including gunman in New York office shooting spree
Four people including a police officer were killed Monday after a gunman walked into a skyscraper in central Manhattan and opened fire in broad daylight, officials said.
Five dead including gunman in New York office shooting
At least four people including a police officer were killed Monday after a gunman walked into a skyscraper in central Manhattan and opened fire in broad daylight, officials said.
Five dead after New York Midtown shooting: US media
Five people including a police officer and the suspected gunman were dead following a shooting Monday in central Manhattan, US media reported.
Gunman dead in New York after Midtown shooting: police
A gunman was dead Monday following a shooting in central Manhattan, New York police said, amid reports a police officer was killed and several civilians struck, provoking a lockdown in the area.
Omega Protein and Ocean Harvesters Urge Science-Based Review Before Imposing New Menhaden Restrictions
Letter from Veteran Biologist Addresses Scientific Questions Over Osprey Declines